| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1074248407304749 Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy VolunteersDavid Geffen School of Medicine at UCLA, Harbor-UCLA Medical Center, Torrance, apshah73{at}yahoo.com
Kaiser Permanente Medical Center, Division of Cardiology, Los Angeles California
Greater Los Angeles VA Healthcare
UCLA-Olive View Medical Center Sylmar
UCLA-Olive View Medical Center Sylmar
UCLA-Olive View Medical Center Sylmar
UCLA-Olive View Medical Center Sylmar Consumption of fish oil (FO) is associated with reduced adverse cardiovascular events. In a randomized, blinded, placebo-controlled trial, 26 subjects (17 men and 9 women; mean age [± SD] 31 ± 3.7 years) received 1 g FO capsule (n = 14) or placebo (1 g of corn oil, n = 12) for 14 days. At day 0 and day 14, heart rate (HR), blood pressure, endothelium-dependent brachial artery flow-mediated vasodilation (EDV), and endothelium-independent nitroglycerin-mediated vasodilation (EIDV) were assessed with ultrasound. FO supplementation resulted in a significant increase in EDV (20.4% ± 13.2% vs 9.9% ± 5.4%; P = .036) and EIDV (32.6% ± 16.8% vs 18.0% ± 14.9%; P = .043). Resting HR decreased by a mean of 5.9 ± 9.4 bpm (FO) compared with placebo (mean increase of 0.73 ± 4.8 bpm [P = .05]). FO supplementation in healthy subjects is associated with improved endothelial function and decreased resting HR.
Key Words: endothelium fish oil hemodynamics
|